Format

Send to

Choose Destination
J Gastroenterol. 2017 Jun;52(6):754-765. doi: 10.1007/s00535-016-1281-2. Epub 2016 Nov 21.

Oral branched-chain amino acid granules improve structure and function of human serum albumin in cirrhotic patients.

Author information

1
Department of Gastroenterology and Hepatology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuou-ku, Kumamoto City, Kumamoto, 860-8556, Japan.
2
Department of Biopharmaceutics, School of Pharmacy, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto City, Kumamoto, 862-0973, Japan.
3
Kumamoto Rosai Hospital, Yatsushiro City, Kumamoto, 866-0826, Japan.
4
Faculty of Pharmaceutical Sciences and DDS Research Institute, Sojo University, Kumamoto City, Kumamoto, 860-0082, Japan.
5
Department of Gastroenterology and Hepatology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuou-ku, Kumamoto City, Kumamoto, 860-8556, Japan. sasakiy@kumamoto-u.ac.jp.

Abstract

BACKGROUND AND AIMS:

The aim of this study was to evaluate structural and functional alterations of human serum albumin (HSA), with a special focus on the oxidized and reduced forms, in patients with chronic liver disease. We also investigated whether oral branched-chain amino acid (BCAA) supplementation could induce structural changes and improve the functions of HSA.

METHODS:

The proportion of reduced and oxidized HSA was determined in 16 healthy controls and in 20 chronic hepatitis and 100 cirrhotic patients with stable conditions. To evaluate the functional properties of HSA, this study focused on the antioxidant and binding functions. The radical scavenging activity and binding ability of purified HSA were measured in 68 participants. After BCAA administration for 6 months, 29 patients were evaluated for HSA structural changes, with 19 out of the 29 patients also analyzed for HSA functional changes.

RESULTS:

There was a significant decrease in the amounts of reduced HSA in conjunction with liver disease progression. Receiver operating characteristic curve analysis demonstrated that the levels of reduced HSA had high accuracy in determining disease progression. Functional alterations were strongly correlated to the levels of reduced HSA. BCAA supplementation led to substantial increases in the amount of reduced HSA. The altered HSA was able to scavenge significantly more radicals and restore the binding ability.

CONCLUSION:

This study describes structural alterations and functional disturbances of HSA in patients with chronic liver disease, and indicates that the levels of reduced HSA might reflect disease progression and the functional properties of HSA. Moreover, oral BCAA supplementation increases the amount of reduced HSA, thereby leading to the restoration of HSA function in cirrhotic patients.

KEYWORDS:

Antioxidant; Biomarker; Oxidative stress; Structure–function relationship

PMID:
27873095
PMCID:
PMC5437197
DOI:
10.1007/s00535-016-1281-2
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center